Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma (HCC)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2009 by Sun Yat-sen University.
Recruitment status was Recruiting

Sponsor:

Collaborator:

Ministry of Health, China

Information provided by:

Sun Yat-sen University

ClinicalTrials.gov Identifier:

NCT00842647

First received: February 11, 2009

Last updated: April 7, 2009

Last verified: April 2009

History of Changes

Tracking Information

First Received Date ^ICMJE

February 11, 2009

Last Updated Date

April 7, 2009

Start Date ^ICMJE

July 2006

Estimated Primary Completion Date

July 2009 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00842647 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma

Official Title ^ICMJE

Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma

Brief Summary

This study prospectively evaluates the accuracy of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case-Only
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

Between July 2006 and July 2009

All the patients who receive hepatomy in our department
Diagnose as HCC
Diagnosis of HCC is confirmed by noninvasive criteria for HCC as used by the American Association for the Study of the Liver guidelines
No history of previous treatments
No pathological diagnosis before treatment

Condition ^ICMJE

Hepatocellular Carcinoma

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

1200

Estimated Completion Date

August 2009

Estimated Primary Completion Date

July 2009 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

All the patients who receive hepatomy in our department
Diagnose as HCC
Diagnosis of HCC is confirmed by noninvasive criteria for HCC as used by the American Association for the Study of the Liver guidelines
No history of previous treatments
No pathological diagnosis before treatment

Gender

Both

Ages

18 Years to 75 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Min-Shan Chen, MD

86-2087343117 ext 86-2087343117

Chminsh@mail.sysu.edu.cn

Location Countries ^ICMJE

China

Administrative Information

NCT Number ^ICMJE

NCT00842647

Other Study ID Numbers ^ICMJE

HCC05

Has Data Monitoring Committee

Yes

Responsible Party

Cancer Center, Sun Yat-sen University

Study Sponsor ^ICMJE

Sun Yat-sen University

Collaborators ^ICMJE

Ministry of Health, China

Investigators ^ICMJE

Not Provided

Information Provided By

Sun Yat-sen University

Verification Date

April 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top